Search research articles
Contact Us
Filters
Showing results (241-250 of 261) with videos related to
Page
of 27
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
November 6, 2013
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
Tracy T Batchelor, Elizabeth R Gerstner, Kyrre E Emblem, et al.
Cancer
|
March 27, 2019
FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial
James M Cleary, Nora K Horick, Nadine Jackson McCleary, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 5, 2016
Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival
Jonas Kloepper, Lars Riedemann, Zohreh Amoozgar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 26, 2015
A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients
Eudocia Q Lee, Thomas J Kaley, Dan G Duda, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 29, 2014
A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma
Theodore S Hong, David P Ryan, Darrell R Borger, et al.
Oncology
|
October 7, 2020
Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients
Reham Abdel-Wahab, Manal M Hassan, Bhawana George, et al.
Nature Biotechnology
|
February 12, 2020
Antibody-mediated delivery of viral epitopes to tumors harnesses CMV-specific T cells for cancer therapy
David G Millar, Rakesh R Ramjiawan, Kosuke Kawaguchi, et al.
Nature Metabolism
|
August 19, 2024
Cancer tissue of origin constrains the growth and metabolism of metastases
Sharanya Sivanand, Yetis Gultekin, Peter S Winter, et al.
Hepatology (Baltimore, Md.)
|
September 2, 2022
Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancers
Bolni Marius Nagalo, Yumei Zhou, Emilien J Loeuillard, et al.
American Journal of Cancer Research
|
April 13, 2017
Genomic and proteomic characterization of ARID1A chromatin remodeller in ampullary tumors
Anca Nastase, Jin Yao Teo, Hong Lee Heng, et al.
Page
of 27
Search research articles
Search
Showing results (241-250 of 261) with videos related to
Sort By:
Page
of 27
Proceedings of the National Academy of Sciences of the United States of America
|
November 6, 2013
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
Tracy T Batchelor, Elizabeth R Gerstner, Kyrre E Emblem, et al.
Cancer
|
March 27, 2019
FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial
James M Cleary, Nora K Horick, Nadine Jackson McCleary, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 5, 2016
Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival
Jonas Kloepper, Lars Riedemann, Zohreh Amoozgar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 26, 2015
A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients
Eudocia Q Lee, Thomas J Kaley, Dan G Duda, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 29, 2014
A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma
Theodore S Hong, David P Ryan, Darrell R Borger, et al.
Oncology
|
October 7, 2020
Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients
Reham Abdel-Wahab, Manal M Hassan, Bhawana George, et al.
Nature Biotechnology
|
February 12, 2020
Antibody-mediated delivery of viral epitopes to tumors harnesses CMV-specific T cells for cancer therapy
David G Millar, Rakesh R Ramjiawan, Kosuke Kawaguchi, et al.
Nature Metabolism
|
August 19, 2024
Cancer tissue of origin constrains the growth and metabolism of metastases
Sharanya Sivanand, Yetis Gultekin, Peter S Winter, et al.
Hepatology (Baltimore, Md.)
|
September 2, 2022
Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancers
Bolni Marius Nagalo, Yumei Zhou, Emilien J Loeuillard, et al.
American Journal of Cancer Research
|
April 13, 2017
Genomic and proteomic characterization of ARID1A chromatin remodeller in ampullary tumors
Anca Nastase, Jin Yao Teo, Hong Lee Heng, et al.
Page
of 27